ImageneBio Inc
40 hedge funds and large institutions have $42.6M invested in ImageneBio Inc in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 9 closing their positions.
2% more capital invested
Capital invested by funds: $41.9M → $42.6M (+$647K)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.35% less ownership
Funds ownership: 78.18% → 75.82% (-2.4%)
11% less funds holding
Funds holding: 45 → 40 (-5)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$391K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$96.1K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$19.6K |
| 5 |
Morgan Stanley
New York
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gilead Sciences
Foster City,
California
|
-$992K |
| 2 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$379K |
| 3 |
DCM
Deuterium Capital Management
Clearwater,
Florida
|
-$103K |
| 4 |
BP
BBR Partners
New York
|
-$89.6K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$58K |
IMA Hedge Fund Activity: Q2 2025 in Review
40 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2025, worth a combined $42.6M — up 1.5% from $41.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of IMA and 4 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 8 added.
The largest buyer was BML Capital Management, adding an estimated $391K. The largest seller was Gilead Sciences, cutting an estimated $992K.
- 40 institutional investors held ImageneBio Inc (IMA) as of Q2 2025, down from 45 in Q1 2025.
- Funds reported $42.6M of ImageneBio Inc stock for Q2 2025, up 1.5% quarter-over-quarter.
- 4 funds opened new ImageneBio Inc positions in Q2 2025 and 9 closed out, a net change of -5 holders.
- The largest ImageneBio Inc buyer in Q2 2025 was BML Capital Management, an estimated $391K added.
- The largest ImageneBio Inc seller in Q2 2025 was Gilead Sciences, an estimated $992K sold.
Based on aggregated 13F filings for Q2 2025.